Publisher
Springer Science and Business Media LLC
Subject
Obstetrics and Gynecology
Reference8 articles.
1. Contreras N-A, Sabadell J, Verdaguer P, Julià C, Fernández- Montolí M-E. Fertility-sparing approaches in atypical endometrial hyperplasia and endometrial cancer patients: current evidence and future directions. Int J Mol Sci. 2022;23:2531. https://doi.org/10.3390/ijms23052531.
2. Gu B, Shang X, Yan M, Li X, Wang W, Wang Q, Zhang C. Variations in incidence and mortality rates of endometrial cancer at the global, regional, and national levels, 1990–2019. Gynecol Oncol. 2021;161(2):573–80. https://doi.org/10.1016/j.ygyno.2021.01.036.
3. Ring KL, Mills AM, Modesitt SC. Endometrial hyperplasia. Obstet Gynecol. 2022;140(6):1061–75. https://doi.org/10.1097/AOG.0000000000004989.
4. Trimble CL, Kauderer J, Zaino R, Silverberg S, Lim PC, Burke JJ, et al. Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study. Cancer. 2006;106:812–9. https://doi.org/10.1002/cncr.21650.
5. Gallos ID, Yap J, Rajkhowa M, et al. Regression, relapse, and live birth rates with fertility-sparing therapy for endometrial cancer and atypical complex endometrial hyperplasia: a systematic review and meta-analysis. Am J Obstet Gynecol. 2012;207(266):e1-12.